Multiple Sclerosis Journal - Experimental, Translational and Clinical · Jul 21, 2026

Establishing demographic-based normative values for neurofilament light chain and glial fibrillary acidic protein in serum and plasma samples

By Borko TL, Ritchie A, Selva S et al.

BACKGROUND: Interpretation of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) levels in blood requires reference ranges from healthy cohorts, accounting for demographic features. OBJECTIVE: To compare serum and plasma NfL and GFAP in healthy individuals, accounting for age, sex, and body mass index (BMI). METHODS: Adolescents through older adults were recruited at Colorado community events and a senior clinic. A neurologist reviewed self-reported medical histories. Paired serum and EDTA plasma samples were assayed using the Quanterix SR-X Simoa Neuro 4-Plex. Log-linear models estimated percent change per year of age, per BMI unit, and sex ratios. GFAP used a piecewise age model (knot at 30 years). Spearman correlation assessed serum-plasma concordance. RESULTS: We enrolled 143 participants (ages = 16.4-85.9; 63.6% female; mean BMI = 26.7). Serum-plasma correlations were strong (NfL ρ = .923; GFAP ρ = .833; both p < .001). In plasma, age was associated with a 2.96% increase in NfL and 2.34% in GFAP per year for ages ≥30. In serum, NfL rose 2.90% and GFAP 2.69% per year (both p < .0001). CONCLUSION: NfL and GFAP are strongly age-dependent and concordant across serum and plasma in healthy individuals. An online calculator provides age-, sex-, and BMI-adjusted reference estimates and serum/plasma conversions.

doi.org/10.1177/20552173261466440Open accessPubMed 42488366Biomarkers

AgingResearch.News